Table 3.

Cumulative incidence of targeted events during the 5-year follow-up

	Treatment	Control group 1 Screened candidate	Control group 2 Beneficiary within inclusion criteria
Diabetes-related complications (all)	12.9%	13.3%	20.4%*
Ischemic heart disease	3.6%	2.9%	2.2%
Stroke	0.7%	1.5%	3.1%
Retinopathy requiring surgery	4.3%	5.1%	6.3%
Neuropathy	3.6%	1.5%	2.4%
End-stage renal disease requiring dialysis	0.7%	1.2%	4.3%*
Intensive care use	5.0%	5.3%	8.4%
Emergency care use	15.1%	18.4%	25.5%**
All-cause hospitalization	51.8%	56.1%	59.4%
Dependency in activities of daily living	2.2%	2.7%	4.3%
All-cause mortality	3.6%	2.9%	2.2%

^*P < 0.05 **P < 0.01 for Fisher's exact test compared with treatment group